Charles PG - Search Results

1

Management of healthcare workers after occupational exposure to hepatitis C virus.

Charles PG, Angus PW, Sasadeusz JJ, Grayson ML. Charles PG, et al. Med J Aust. 2003 Aug 4;179(3):153-7. doi: 10.5694/j.1326-5377.2003.tb05475.x. Med J Aust. 2003. PMID: 12885285

2

The dearth of new antibiotic development: why we should be worried and what we can do about it.

Charles PG, Grayson ML. Charles PG, et al. Med J Aust. 2004 Nov 15;181(10):549-53. doi: 10.5694/j.1326-5377.2004.tb06444.x. Med J Aust. 2004. PMID: 15540967

3

Point-of-care tests for lower respiratory tract infections.

Charles PG, Grayson ML. Charles PG, et al. Med J Aust. 2007 Jul 2;187(1):36-9. doi: 10.5694/j.1326-5377.2007.tb01112.x. Med J Aust. 2007. PMID: 17605701 Review.

4

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML. Charles PG, et al. Clin Infect Dis. 2004 Feb 1;38(3):448-51. doi: 10.1086/381093. Epub 2004 Jan 12. Clin Infect Dis. 2004. PMID: 14727222

5

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.

Bishop E, Melvani S, Howden BP, Charles PG, Grayson ML. Bishop E, et al. Among authors: charles pg. Antimicrob Agents Chemother. 2006 Apr;50(4):1599-602. doi: 10.1128/AAC.50.4.1599-1602.2006. Antimicrob Agents Chemother. 2006. PMID: 16569895 Free PMC article.

6

Conundrums in community-acquired pneumonia.

Charles PG, Johnson PD, Grayson ML. Charles PG, et al. Med J Aust. 2006 Aug 7;185(3):131-2. doi: 10.5694/j.1326-5377.2006.tb00496.x. Med J Aust. 2006. PMID: 16893350 No abstract available.

7

Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)?

Charles PG, Ananda-Rajah M, Johnson PD, Grayson ML. Charles PG, et al. Med J Aust. 2004 Nov 1;181(9):515; author reply 515-6. Med J Aust. 2004. PMID: 15516202 No abstract available.

8

It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia.

Charles PG, Cheng AC, Grayson ML. Charles PG, et al. Intern Med J. 2014 Nov;44(11):1148. doi: 10.1111/imj.12571. Intern Med J. 2014. PMID: 25367733 No abstract available.

9

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.

Teh B, Grayson ML, Johnson PD, Charles PG. Teh B, et al. Among authors: charles pg. Clin Microbiol Infect. 2012 Apr;18(4):E71-3. doi: 10.1111/j.1469-0691.2011.03759.x. Epub 2012 Jan 27. Clin Microbiol Infect. 2012. PMID: 22284533 Free article.

10

Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia.

Ananda-Rajah MR, Charles PG, Melvani S, Burrell LL, Johnson PD, Grayson ML. Ananda-Rajah MR, et al. Among authors: charles pg. Scand J Infect Dis. 2008;40(4):293-300. doi: 10.1080/00365540701663381. Scand J Infect Dis. 2008. PMID: 17918017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters